PlasmaTech Biopharmaceuticals
4848 Lemmon Avenue
Suite 517
Dallas
Texas
75219
United States
Tel: 214- 905-5100
Fax: 214-905-5101
Website: http://www.plasmatechbio.com/
Email: info@plasmatechbio.com
10 articles about PlasmaTech Biopharmaceuticals
-
Abeona Therapeutics, Formerly Known As PlasmaTech Biopharmaceuticals To Ring The Nasdaq Stock Market Closing Bell
6/19/2015
-
PlasmaTech Biopharmaceuticals Appoints Alpha-1 Expert Robert Sandhaus, MD, Ph.D. To Its Scientific Advisory Board
4/7/2015
-
PlasmaTech Biopharmaceuticals' Announces $5 Million Private Placement
4/2/2015
-
PlasmaTech Biopharmaceuticals' Partner Hanmi Pharma Receives Marketing Approval For MuGard In Korea
3/31/2015
-
PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference - NEW TIME SLOT
3/10/2015
-
PlasmaTech Biopharmaceuticals' Announces Initiation Of Enrollment Of MuGard Trial For Afinitor (Everolimus; Novartis) - Related Stomatitis At University of California, Los Angeles (UCLA) Breast Cancer Center
3/5/2015
-
PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference
3/3/2015
-
PlasmaTech Biopharmaceuticals To Present At Biotech Showcase 2015
1/14/2015
-
PlasmaTech Biopharmaceuticals Announces Pricing Of $14,000,000 Public Offering And Listing On NASDAQ
12/19/2014
-
PlasmaTech Biopharmaceuticals Appoints World Leading Plasma Experts To Scientific Advisory Board
10/29/2014